APA (7th ed.) Citation

SC, J., S, C., N, A., E, H., J, S., X, Z., . . . A, V. (2026). CTLA4-Ig + Anti-IL-6/IL-6R Treatment Results in Long-term Allograft Survival and Function in Highly HLA-sensitized Patients. Transplantation direct, 12(7), e1952. https://doi.org/10.1097/TXD.0000000000001952

Chicago Style (17th ed.) Citation

SC, Jordan, et al. "CTLA4-Ig + Anti-IL-6/IL-6R Treatment Results in Long-term Allograft Survival and Function in Highly HLA-sensitized Patients." Transplantation Direct 12, no. 7 (2026): e1952. https://doi.org/10.1097/TXD.0000000000001952.

MLA (9th ed.) Citation

SC, Jordan, et al. "CTLA4-Ig + Anti-IL-6/IL-6R Treatment Results in Long-term Allograft Survival and Function in Highly HLA-sensitized Patients." Transplantation Direct, vol. 12, no. 7, 2026, p. e1952, https://doi.org/10.1097/TXD.0000000000001952.